Jerusalem-based startup Raziel Therapeutics developed an injectable molecule that melts away fat cells
The key to fighting obesity is through diet and lifestyle, experts agree. But a new “fat-melting” injection developed by an Israeli startup may help us
Atox Bio Announces Enrollment of First Patient in Acute Kidney Injury (AKI) Phase 2 Study
May 30, 2018 – Atox Bio, a clinical stage biotechnology company developing novel therapies for critically ill patients, announced that the first patient has been enrolled
BiondVax is carrying clinical trials out on their universal flu vaccine candidate M-001 in both the US and Europe
May 14 – BioWorld reported that BiondVax puts pegs in place for final push in universal flu vaccine effort http://www.bioworld.com/content/biondvax-puts-pegs-place-final-push-universal-flu-vaccine-effort . Clinical trials on the BiondVax vaccine are
BrainQ raises $5.3M to treat neurological disorders with the help of AI
May 15, 2018 – BrainQ, a Jerusalem-based digital therapeutics startup that aims to help stroke victims and those with spinal cord injuries treat their injuries with the
FDA Clearance Granted to BrainsWay for Next Generation Stimulator
May 7, 2018 – BrainsWay will now have the most advanced stimulator on the market, with enhanced features that increase the ease of use for physicians
Tyson leads $2.2m investment in JLM based Future Meat Technologies
May 2, 2018 – Jerusalem-based biotechnology company Future Meat Technologies has received $2.2 million in a seed investment funding round led by Tyson Ventures, the venture
NovellusDx Completes $6M Equity Financing
April 30, 2018 – NovellusDx, a Jerusalem, Israel-based functional genomics company, completed a $6m equity financing. Backers in the round, which adds to the nearly
VRHealth selected for Excellence in Healthcare Future Tech Award at 2018 Las Vegas Smart Health Conference
April 27, 2018 – The Smart Health Conference in Las Vegas has selected VRHealth, the Israel-based, virtual reality for physical therapy technology company, as a Top 10
Cordis and Medinol Announce First U.S. Commercial Implants of Innovative EluNIR™ Drug-Eluting Stent
January 11, 2018 – Cordis, a Cardinal Health company, and Medinol announced that the first commercial cases using the EluNIR™ drug-eluting stent (DES) in the United
